Summary
Artificial intelligence is being used to tailor cancer treatments and identify new uses for existing medicines, with some technologies already benefiting patients. Recent developments include positive Phase 3 trial results from Moderna and Merck for an individualized neoantigen therapy for melanoma, which utilizes AI algorithms.